The primacy of IL-6 in IPS?

Blood. 2015 Apr 9;125(15):2320-2. doi: 10.1182/blood-2015-02-629816.

Abstract

In this issue of Blood, Varelias and colleagues demonstrate a central role of interleukin (IL)-6 in idiopathic pneumonia syndrome (IPS) after allogeneic stem cell transplantation (SCT) in both mice and humans.

Publication types

  • Comment

MeSH terms

  • Acute Lung Injury / etiology*
  • Animals
  • Cyclosporine / adverse effects*
  • Female
  • Immunosuppressive Agents / adverse effects*
  • Interleukin-17 / immunology*
  • Interleukin-6 / immunology*
  • Lung / pathology*
  • Stem Cell Transplantation / adverse effects*

Substances

  • Immunosuppressive Agents
  • Interleukin-17
  • Interleukin-6
  • Cyclosporine